SELLAS Life Sciences Virtual R&D Day -- October 29, 2025: Advancing Novel Therapies in Acute Myeloid Leukemia (AML): An Overview of the Ongoing Phase 3 REGAL Trial of Galinpepimut-S (GPS) and SLS009 ...
KENNEDY SPACE CENTER — Citing the proposed budget cuts by the Trump administration, NASA announced on Friday that after the Artemis III mission — where Americans will return to the moon — the rocket ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...
About SELLAS Life Sciences Group Inc. SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback